Jones I R, Owens D R, Luzio S, Williams S, Hayes T M
Department of Medicine, University of Wales College of Medicine, Cardiff, UK.
Diabetologia. 1989 Sep;32(9):668-77. doi: 10.1007/BF00274255.
Considerable disagreement exists regarding the levels of immunoreactive glucose dependent insulinotropic polypeptide in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Glucose dependent insulinotropic polypeptide levels were therefore studied during oral glucose and mixed meal tolerance tests in normal subjects (n = 31) and newly presenting previously untreated patients with Type 2 diabetes mellitus (n = 68). The tests were performed in random order after overnight fasts and blood samples were taken at 30 min intervals for 4 h. During the oral glucose tolerance test plasma glucose dependent insulinotropic polypeptide levels increased in the normal subjects from a fasting value of 20 +/- 3 pmol/l to a peak of 68 +/- 5 pmol/l at 30 min and in the Type 2 diabetic patients from a similar fasting level of 27 +/- 3 pmol/l to a higher peak value of 104 +/- 6 pmol/l at 30 min (p less than 0.001). Glucose dependent insulinotropic polypeptide levels were significantly higher in the diabetic patients compared with the normal subjects from 30-90 min (p less than 0.01-0.001) following oral glucose. During the meal tolerance test glucose dependent insulinotropic polypeptide levels increased in the normal subjects from a pre-prandial value of 22 +/- 4 pmol/l to a peak of 93 +/- 6 pmol/l at 90 min and in the Type 2 diabetic patients from a similar basal level of 25 +/- 2 pmol/l to a higher peak of 133 +/- 7 pmol/l at 60 min. Glucose dependent insulinotropic polypeptide concentrations were significantly higher in Type 2 diabetic patients compared with the normal subjects at 30 min (p less than 0.001), 60 min (p less than 0.01) and from 210-240 min (p less than 0.05) during the meal tolerance test. The groups were subdivided on the basis of degree of obesity and glucose dependent insulinotropic polypeptide concentrations were still higher in the diabetic subgroups compared with the normal subjects matched for weight. Type 2 diabetes mellitus is associated with an exaggerated glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals which is independent of any effect of obesity.
关于2型(非胰岛素依赖型)糖尿病患者中免疫反应性葡萄糖依赖性促胰岛素多肽的水平存在相当大的分歧。因此,我们在正常受试者(n = 31)和新诊断的未经治疗的2型糖尿病患者(n = 68)中进行口服葡萄糖耐量试验和混合餐耐量试验,研究葡萄糖依赖性促胰岛素多肽水平。试验在过夜禁食后随机进行,在4小时内每隔30分钟采集血样。在口服葡萄糖耐量试验期间,正常受试者血浆葡萄糖依赖性促胰岛素多肽水平从空腹值20±3 pmol/l在30分钟时升至峰值68±5 pmol/l,2型糖尿病患者从类似的空腹水平27±3 pmol/l在30分钟时升至更高的峰值104±6 pmol/l(p<0.001)。口服葡萄糖后30 - 90分钟,糖尿病患者的葡萄糖依赖性促胰岛素多肽水平显著高于正常受试者(p<0.01 - 0.001)。在混合餐耐量试验期间,正常受试者血浆葡萄糖依赖性促胰岛素多肽水平从餐前值22±4 pmol/l在90分钟时升至峰值93±6 pmol/l,2型糖尿病患者从类似的基础水平25±2 pmol/l在60分钟时升至更高的峰值133±7 pmol/l。在混合餐耐量试验期间,2型糖尿病患者在30分钟(p<0.001)、60分钟(p<0.01)以及210 - 240分钟(p<0.05)时的葡萄糖依赖性促胰岛素多肽浓度显著高于正常受试者。根据肥胖程度对两组进行细分,与体重匹配的正常受试者相比,糖尿病亚组的葡萄糖依赖性促胰岛素多肽浓度仍然更高。2型糖尿病与对口服葡萄糖和混合餐的葡萄糖依赖性促胰岛素多肽反应过度有关,且这种反应与肥胖的任何影响无关。